¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Ergotamine Tartrate W/Caffeine Rect"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® caffeine ÇÑ±Û Ä«ÆäÀÎ
¼³¸í   
  Ä¿ÇÇ, È«Â÷ µî¿¡ µé¾î Àִ ȭÇй°Áú. ´ë³ú¿¡ ÀÛ¿ëÇÏ¿© ´ë³ú¸¦ ÀÚ±ØÇϰí ÄáÆÏ, ±ÙÀ°, ½ÉÀåÀǠȰµ¿À» ÀÚ±ØÇϴ ¿ªÇÒÀ» Çϴ ¾à¸®ÀÛ¿ëÀÌ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • caffeine
    Ä«ÆäÀÎ
  • ergotamine
    ¿¡¸£°íŸ¹Î
  • tartrate
    ÁÖ¼®»ê¿°, Ÿ¸£Å¸¸£»ê¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • caffeine
    Ä«ÆäÀÎ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • caffeine
    Ä«ÆäÀÎ
  • ergotamine
    ¿¡¸£°íŸ¹Î
  • tartrate
    ÁÖ¼®»ê¿°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ergotamine
  • caffeine
    Ä«ÆäÀÎ
  • caffeine
    Ä«ÆäÀÎ
  • caffeine - related disorder
    Ä«ÆäÀÎ °ü·ÃÀå¾Ö(º´)
  • caffeine acetate
    ¾Æ¼¼Æ®»ê Ä«ÆäÀÎ.
  • ethylenediamine tartrate =EDT
    Ÿ¸£Å¸¸£»ê ¿¡Æ¿·»µð¾Æ¹Î.
  • levorphanol tartrate =NND
    ÁÖ¼®»ê(ñÐà´ß«)·¹º¸¸£ÆÄ³î.
  • lithium caffeine sulfonate
    ¼úÆù»êÄ«ÆäÀθ®Æ¬.
  • pentolinium tartrate
    ÁÖ¼®»ê(ñÐà´ß«).
  • tartrate
    ŸŸ¸£»ê¿°, ÁÖ¼®»ê¿°(ñ¹à´ß«æú).
  • tartrate resistant acid phosphatase
    ŸŸ¸£»ê¿°³»¼º »ê¼º Æ÷½ºÆÄŸÁ¦
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • caffeine
    Ä«ÆäÀÎ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • caffeine
    Ä«ÆäÀÎ
  • ergotamine
    ¿¡¸£°íŸ¹Î
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
APC acetylsalicylic acid, phenacetin, and caffeine; activated protein C; adenoidal-pharyngeal-conjunctiv...
DHE Di-Hydro-Ergotamine
rect rectal; rectification, rectified; rectum; rectus [muscle]
TRAP Tartrate Resistant Acid Phosphatase
ACP accessory conduction pathway; acid phosphatase; acyl carrier protein; American College of Pathologis...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TrACP 5-tartrate-resistant acid phosphatase
TRAP Tartrate resistant acid phosphatase
TRAPase Tartrate-resistant acid phosphatase
TRAP+ Tartrate-resistant acid phosphatase-positive
CSC 8-(3-chlorostyryl) caffeine
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • caffeine
    Ä«ÆäÀÎ
    µ¿ÀǾî=caffeima. Ä¿Çdzª Â÷¿¡ ÇÔÀ¯µÈ ¼ººÐÀÌ´Ù. ¾à¸® ÀÛ¿ëÀ¸·Î´Â ÁßÃß ÈïºÐ ÀÛ¿ë°ú °ñ°Ý±Ù ÈïºÐ ÀÛ¿ë, ÆòȰ±Ù ÀÌ¿ÏÀÛ¿ë°ú ½É±Ù ÈïºÐÀÛ¿ë°ú ÀÌ´¢ ÀÛ¿ëÀÌ ÀÖ´Ù. ÁßÃßÈïºÐÁ¦ ¹× È£Èí ÈïºÐÁ¦·Î »ç¿ëµÇ¸ç µÎÅëÀ» ÇØ¼Ò½Ãų ¸ñÀûÀ¸·Îµµ ³»º¹½ÃŲ´Ù. Ä«ÆäÀÎ ¹× sodium benzoate ÇÕÁ¦´Â ¼ö¿ë¾×À¸·Î ÇÏ¿© ÁÖ»ç¿ëÀ¸·Î »ç¿ëµÇ°í ÀÖ´Ù.
  • ergotamine
    ¿¡¸£°íŸ¹Î
    1920³â¿¡ StollÀÌ ÃßÃâÇÑ ¸Æ°¢ÀÇ À¯È¿ ¾ËÄ®·ÎÀ̵å.
  • ergotamine tertate
    ÁÖ¼®»ê ¸Æ°¢
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
ergotamine <chemical> A vasoconstrictor found in ergot of central europe. It is an alpha-1 selective adrenergic agonist and is commonly used in the treatment of migraine headaches.
Pharmacological action: adrenergic alpha-agonists, analgesics, non-narcotic, vasoconstrictor agents.
Chemical name: Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-
(12 Dec 1998)
ergotamine derivatives Analogs and derivatives of ergotamine.
(12 Dec 1998)
caffeine <chemical> A xanthine derivative that elevates cAMP levels in cells by inhibiting phosphodiesterases.
(18 Nov 1997)
caffeine and sodium benzoate A mixture of equal parts of sodium benzoate and caffeine, used to meet the indication of caffeine.
(05 Mar 2000)
caffeine and sodium salicylate A mixture of sodium salicylate and caffeine used for the relief of headache and neuralgia.
(05 Mar 2000)
caffeine citrate Citrated caffeine, a mixture of equal parts of caffeine and citric acid.
(05 Mar 2000)
caffeine hydrate Monohydrate of caffeine, a central nervous system stimulant.
(05 Mar 2000)
acid tartrate A salt of tartaric acid which contains an acid group still capable of combining with a base; e.g., bitartrate.
(05 Mar 2000)
antimony potassium tartrate <chemical> Bis(mu-(2,3-dihydroxybutanedioato(4-)-o(1),o(2):o(3),o(4)))diantimonate(2-) dipotassium trihydrate, stereoisomer. A schistosomicide possibly useful against other parasites. It has irritant emetic properties and may cause lethal cardiac toxicity among other adverse effects.
Pharmacological action: schistosomicides.
Chemical name: Antimonate(2-), bis(mu-(2,3-dihydroxybutanedioato(4-)-O1,O2:O3,O4))di-, dipotassium, trihydrate, stereoisomer
(12 Dec 1998)
antimony sodium tartrate Na(SbO)C4H4O6;used in the treatment of schistosomiasis, and as an emetic.
Synonym: sodium antimonyl tartrate.
(05 Mar 2000)
bismuth sodium tartrate A basic sodium bismuth tartrate; an antisyphilitic agent.
(05 Mar 2000)
butorphanol tartrate (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol tartrate;a potent mixed agonist/antagonist narcotic analgesic agent.
(05 Mar 2000)
pentolinium tartrate <chemical> A nicotinic antagonist that has been used as a ganglionic blocking agent in hypertension.
Pharmacological action: antihypertensive agents, ganglionic blockers, nicotinic antagonists.
Chemical name: Pyrrolidinium, 1,1'-(1,5-pentanediyl)bis(1-methyl-, salt with (R-(R*,R*))-2,3-dihydroxybutanedioic acid (1:2)
(12 Dec 1998)
meso-tartrate dehydrogenase <enzyme> Forms dihydroxyfumarate; distinguished from EC 1.1.1.93 which forms oxaloglycollate
Registry number: EC 1.3.1.7
(26 Jun 1999)
metoprolol tartrate 1-Isopropylamino-3-[p-(2-methoxyethyl)phenoxy]-2-propanol (2:1) dextrotartrate salt;a beta-adrenergic blocking agent used in the treatment of hypertension; exhibits some cardioselectivity.
(05 Mar 2000)
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 1 ÆäÀÌÁö: 1
  • Ergotamine Tartrate W/Caffeine Rect - »õâ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • tartrate
    ÁÖ¼®»ê¿°
  • rect-
    (¿¬°áÇü)Á÷;Á¤ÀÇ ¶æ(¸ðÀ½ ¾Õ¿¡¼­´Â rect-)
  • rect.
    receipt;rectangle;rectangular;rectified;rector;rectory
  • caffeine
    Ä«ÆäÀÎ
  • caffeine
    Ä«ÆäÀÎ
  • caffeine-free
    Ä«ÆäÀÎ ¾ø´Â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á